A5101448243- Colorectal Cancer Surgical Treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Intraperitoneal and Appendiceal Malignancies
- Appendicitis Diagnosis and Management
- MicroRNA in disease regulation
- Marriage and Sexual Relationships
- Cancer-related molecular mechanisms research
- Anorectal Disease Treatments and Outcomes
- Circular RNAs in diseases
- Colorectal Cancer Screening and Detection
- Stoma care and complications
- Gastric Cancer Management and Outcomes
- Infectious Diseases and Tuberculosis
- Minimally Invasive Surgical Techniques
- Trauma Management and Diagnosis
- Airway Management and Intubation Techniques
- Tracheal and airway disorders
- Vascular Procedures and Complications
- Surgical site infection prevention
- Radiation Dose and Imaging
- Multiple and Secondary Primary Cancers
- Chronic Lymphocytic Leukemia Research
- Vascular anomalies and interventions
- Hepatitis B Virus Studies
- Surgical Sutures and Adhesives
University of Saskatchewan
2024
Norfolk and Norwich University Hospitals NHS Foundation Trust
2023
National University of Avellaneda
2023
University of Birmingham
2023
ESCP Business School
2023
ESCP Business School
2023
NIHR Birmingham Biomedical Research Centre
2023
South Warwickshire NHS Foundation Trust
2020-2021
Khawaja Farid Social Security Hospital
2021
National Health Service
2020
Introduction The triple assessment for a lump in the breast is standard practice and robustness of towards diagnosis cancer crucial. combination modalities, physical examination, imaging (mammogram ultrasound), fine-needle aspiration cytology (FNAC) more accurate than any modality alone. Aim To examine combined individual predictive values examination (P), mammography (M), ultrasound (U), FNAC (C), with core biopsy (B) - cancer. Methods obtain results (B), we examined records 124 patients...
This study sought to assess the effectiveness of biomarker-directed personalized therapies for treatment non-small cell lung cancer (NSCLC) targeting actionable genetic mutations like EGFR, ALK, and PD-L1. A prospective observational was performed on 200 NSCLC patients with established alterations, divided into four groups: EGFR-mutant, ALK-rearranged, PD-L1-positive, wild-type (no biomarkers). Patients were treated targeted (e.g., EGFR inhibitors, ALK PD-1 inhibitors) or platinum-based...
Abstract Background Anastomotic leak affects 8 per cent of patients after right colectomy with a 10-fold increased risk postoperative death. The EAGLE study aimed to develop and test whether an international, standardized quality improvement intervention could reduce anastomotic leaks. Methods internationally intended protocol, iteratively co-developed by multistage Delphi process, comprised online educational module introducing stratification, intraoperative checklist, harmonized surgical...
Wilkie's syndrome, a rare cause of intestinal obstruction, is related to anatomical and mechanical factors associated with the reduction retroperitoneal fat padding. The diagnostic challenges identifying vascular constriction between aorta superior mesenteric artery have been answered by advances in field computed tomography. Despite confusion dysmotility conservative therapy nutritional supplementation initial approach duodenojejunostomy favoured if non-surgical treatment fails.We present...
In 2004, the World Health Organization classified renal oncocytomas as benign neoplasms of kidney. There are reports subtypes tumors, with similar histological morphology to oncocytoma, but malignant potential, one these tumors is eosinophilic variant chromophobe cell carcinoma. It important characterize features and subtype tumor, this predicts biological behavior cancer-specific survival rate. A rare case a liver metastasis from focal area carcinoma mixed in oncocytoma 69-year-old woman...
Abstract Aim Micro RNA s (mi s) from tumour tissue and common gene mutations were studied to determine whether they predict the development of metastasis in patients with Dukes B colorectal cancer. Method Patients who underwent curative resection for cancer subsequently developed distant metastatic disease at some stage following 5 years (‘high‐risk B’) compared case‐matched controls A, (no metastases, ‘low‐risk C without any detectable follow‐up. Mi adjacent normal ( KRAS , BRAF PIK 3 CA )...
Introduction: Salvage chemotherapy and ASCT remains the standard of care in patients (pts) with relapsed/refractory (RR) DLBCL. CCTG trial LY.12 established rituximab combined gemcitabine, dexamethasone cisplatin (R-GDP) as a this population (Crump JCO 2014), low incidence febrile neutropenia (12%) infection. Methods: LY.17 is an ongoing multi-arm randomized phase II “pick winner” evaluating novel salvage therapy R-GDP RR-DLBCL pts post anthracycline based failure. The first experimental arm...